BA
NVO

Boston Advisors’s Novo Nordisk NVO Stock Holding History

Boston Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,700
Closed -$229K – 653
2018
Q3 		$229K Hold
9,700
– – 0.01% 608
2018
Q2 		$224K Sell
9,700
-14,444
-60% -$343K 0.01% 627
2018
Q1 		$595K Sell
24,144
-2,186
-8% -$57.4K 0.02% 466
2017
Q4 		$707K Buy
26,330
+11,130
+73% +$283K 0.02% 435
2017
Q3 		$366K Sell
15,200
-200
-1% -$4.52K 0.01% 546
2017
Q2 		$330K Sell
15,400
-1,600
-9% -$32.3K 0.01% 562
2017
Q1 		$291K Sell
17,000
-4,400
-21% -$76.6K 0.01% 567
2016
Q4 		$384K Sell
21,400
-24,050
-53% -$436K 0.01% 522
2016
Q3 		$945K Sell
45,450
-1,970
-4% -$48.8K 0.02% 361
2016
Q2 		$1.27M Sell
47,420
-4,220
-8% -$116K 0.03% 315
2016
Q1 		$1.4M Sell
51,640
-500
-1% -$13.4K 0.03% 286
2015
Q4 		$1.51M Buy
52,140
+17,490
+50% +$484K 0.04% 283
2015
Q3 		$940K Buy
34,650
+500
+1% +$14.2K 0.04% 385
2015
Q2 		$935K Hold
34,150
– – 0.04% 301
2015
Q1 		$912K Sell
34,150
-700
-2% -$16.1K 0.04% 303
2014
Q4 		$737K Buy
34,850
+300
+0.9% +$6.7K 0.03% 293
2014
Q3 		$823K Hold
34,550
– – 0.04% 294
2014
Q2 		$798K Hold
34,550
– – 0.03% 302
2014
Q1 		$789K Buy
34,550
+100
+0.3% +$2.13K 0.04% 292
2013
Q4 		$636K Buy
34,450
+12,750
+59% +$222K 0.03% 317
2013
Q3 		$367K Buy
21,700
+6,700
+45% +$113K 0.02% 362
2013
Q2 		$232K Buy
+15,000
New +$250K 0.01% 476

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Boston Advisors's NVO Position: Q4 2018 in Review

Boston Advisors sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 9,700 shares — an estimated $229K sold.

Boston Advisors first reported a position in NVO in Q2 2013 and held it in 22 quarters. The position peaked at $1.51M in Q4 2015. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • Boston Advisors reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
  • Boston Advisors sold 9,700 Novo Nordisk shares in Q4 2018, an estimated $229K.
  • Boston Advisors first reported a position in Novo Nordisk in Q2 2013 and held it in 22 quarters.
  • Boston Advisors's Novo Nordisk position peaked at $1.51M in Q4 2015.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Boston Advisors's 13F filing for Q4 2018, filed 16 Jan 2019.